Filing metadata

Accession number
0000950170-24-075488
Form type
Form 4
Filer
Ultragenyx Pharmaceutical Inc.
CIK
CIK 1515673
Filed
Jun 20, 2024
Reporting period
Jun 18, 2024
Description
Insider transaction

Explore SEC Filings Hub